到 2025 年北美下一代测序市场 - 按产品（平台、服务、消耗品）进行区域分析和预测；服务（基因组测序、外显子组测序、重测序、靶向测序和其他测序技术）；应用（诊断、药物发现、精准医学和其他应用）；和最终用户（学术和研究机构、制药和生物技术公司、医院诊所和其他最终用户）以及国家/地区
No. of Pages: 233 | Report Code: TIPRE00004657 | Category: Life Sciences
No. of Pages: 233 | Report Code: TIPRE00004657 | Category: Life Sciences
北美下一代测序市场预计将从 2017 年的 23.785 亿美元增至 2025 年的 107.33 亿美元。该市场预计将以 20.7% 的复合年增长率增长2018-2025。
市场的增长是由测序价格下降和癌症患病率上升等因素推动的。然而，由于该地区基因数据相关的风险以及下一代测序先进技术的高成本，该市场可能会受到影响。
近年来，案例癌症的发病率一直在急剧增加，预计未来几年这一趋势将保持不变。生活方式的改变导致更多地接触致癌因素。 2015 年，美国癌症协会估计美国发现了 1,658,370 例癌症病例。如果在初始阶段诊断和治疗，癌症是可以治愈的。使用下一代测序 (NGS) 方法进行的癌症测序可提供更多信息。此外，NGS 还有助于癌症的诊断和治疗。癌症病例的增加预计将成为未来几年推动 NSG 市场需求的主要因素。
此外，生物标志物是医学体征，是通过观察观察到的医疗状态的指标。病人体外。生物标志物用于临床研究和临床实践。下一代测序（NGS）是基因组技术在致癌生物标志物发现和诊断方面最重要的进步之一。 NGS 有助于发现用于识别遗传疾病的生物标志物。 HiSeq2500 和 MiSeq Illumina 测序仪用于大规模生物标志物发现。精准医学是利用个体的基因组信息为个体提供有针对性的治疗。下一代测序技术是精准医疗的关键驱动力，并提高了其准确性、速度和成本。 NGS 能够快速对人体基因组的大部分进行测序，并有助于制定精准医疗。
生物标志物的发现有利于早期诊断和区分疾病类型。而精准医学能够治疗疾病，NGS 在其应用中发挥着至关重要的作用，为其未来提供了一系列机会。
美国预计将引领市场北美地区由于该国不断增加的有机和无机增长战略。此外，美国市场参与者越来越关注以及赠款和资助。 NIH 的资金是主要驱动因素之一。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在北美地区贡献最大份额。
图表：墨西哥下一代测序市场收入及 2025 年预测（百万美元）
北美下一代测序 - 市场细分
Strategic insights for North America Next Generation Sequencing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2017 | US$ 2,378.5 Million |
| Market Size by 2025 | US$ 10,733.0 Million |
| Global CAGR (2018 - 2025) | 20.7% |
| Historical Data | 2015-2016 |
| Forecast period | 2018-2025 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Next Generation Sequencing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The North America Next Generation Sequencing Market is valued at US$ 2,378.5 Million in 2017, it is projected to reach US$ 10,733.0 Million by 2025.
As per our report North America Next Generation Sequencing Market, the market size is valued at US$ 2,378.5 Million in 2017, projecting it to reach US$ 10,733.0 Million by 2025. This translates to a CAGR of approximately 20.7% during the forecast period.
The North America Next Generation Sequencing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Next Generation Sequencing Market report:
The North America Next Generation Sequencing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Next Generation Sequencing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Next Generation Sequencing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Next Generation Sequencing Market
